Clinical Trial: Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasm

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title: A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase II/III Clinical Trial to Compare the Safety and Efficacy of NABOTA Versus BOTOX in Treatment of Essential

Brief Summary: The purpose of this study is to evaluate the Efficacy and Safety of NABOTA in treatment of essential blepharospasm

Detailed Summary:
Sponsor: Daewoong Pharmaceutical Co. LTD.

Current Primary Outcome: The change from baseline in Scott's Scale Score [ Time Frame: At 4 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Daewoong Pharmaceutical Co. LTD.

Dates:
Date Received: October 24, 2016
Date Started: October 2016
Date Completion: December 2017
Last Updated: October 26, 2016
Last Verified: October 2016